These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28707958)

  • 41. Dose Reduction in Contrast-Enhanced Cervical MR Angiography: Field Strength Dependency of Vascular Signal Intensity, Contrast Administration, and Arteriographic Quality.
    Dehkharghani S; Qiu D; Albin LS; Saindane AM
    AJR Am J Roentgenol; 2015 Jun; 204(6):W701-6. PubMed ID: 26001259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noncontrast-enhanced three-dimensional magnetic resonance aortography of the thorax at 3.0 T using respiratory-compensated T1-weighted k-space segmented gradient-echo imaging with radial data sampling: preliminary study.
    Amano Y; Takahama K; Kumita S
    Invest Radiol; 2009 Sep; 44(9):548-52. PubMed ID: 19652612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined large field-of-view MRA and time-resolved MRA of the lower extremities: impact of acquisition order on image quality.
    Riffel P; Haneder S; Attenberger UI; Brade J; Schoenberg SO; Michaely HJ
    Eur J Radiol; 2012 Oct; 81(10):2754-8. PubMed ID: 22185939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Noncontrast 3D steady-state free-precession magnetic resonance angiography of the whole chest using nonselective radiofrequency excitation over a large field of view: comparison with single-phase 3D contrast-enhanced magnetic resonance angiography.
    Krishnam MS; Tomasian A; Deshpande V; Tran L; Laub G; Finn JP; Ruehm SG
    Invest Radiol; 2008 Jun; 43(6):411-20. PubMed ID: 18496046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study.
    Tombach B; Reimer P; Bremer C; Allkemper T; Engelhardt M; Mahler M; Ebert W; Heindel W
    NMR Biomed; 2004 Nov; 17(7):500-6. PubMed ID: 15523717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contrast-enhanced magnetic resonance angiography in rabbits: evaluation of the gadolinium-based agent p846 and the iron-based blood pool agent p904 in comparison with gadoterate meglumine.
    Kinner S; Maderwald S; Parohl N; Albert J; Corot C; Robert P; Barkhausen J; Vogt FM
    Invest Radiol; 2011 Aug; 46(8):524-9. PubMed ID: 21577130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol.
    Shahrouki P; Khan SN; Yoshida T; Iskander PJ; Ghahremani S; Finn JP
    Pediatr Radiol; 2022 Mar; 52(3):501-512. PubMed ID: 34936018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pedal angiography in peripheral arterial occlusive disease: first-pass i.v. contrast-enhanced MR angiography with blood pool contrast medium versus intraarterial digital subtraction angiography.
    Kos S; Reisinger C; Aschwanden M; Bongartz GM; Jacob AL; Bilecen D
    AJR Am J Roentgenol; 2009 Mar; 192(3):775-84. PubMed ID: 19234277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine.
    Klessen C; Hein PA; Huppertz A; Voth M; Wagner M; Elgeti T; Kroll H; Hamm B; Taupitz M; Asbach P
    Invest Radiol; 2007 Sep; 42(9):659-64. PubMed ID: 17700282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Height and Blood Volume on Venous Enhancement After Gadolinium-Based Contrast Administration in MR Venography: A Paradigm Challenge and Implications for Clinical Imaging.
    Dehkharghani S; Williams TR; Qiu D; Saindane AM
    AJR Am J Roentgenol; 2016 Sep; 207(3):621-7. PubMed ID: 27304717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Equilibrium-phase MR angiography: Comparison of unspecific extracellular and protein-binding gadolinium-based contrast media with respect to image quality.
    Erb-Eigner K; Taupitz M; Asbach P
    Contrast Media Mol Imaging; 2016; 11(1):71-6. PubMed ID: 26265484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 4D phase contrast MRI at 3 T: effect of standard and blood-pool contrast agents on SNR, PC-MRA, and blood flow visualization.
    Bock J; Frydrychowicz A; Stalder AF; Bley TA; Burkhardt H; Hennig J; Markl M
    Magn Reson Med; 2010 Feb; 63(2):330-8. PubMed ID: 20024953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measuring aortic diameter with different MR techniques: comparison of three-dimensional (3D) navigated steady-state free-precession (SSFP), 3D contrast-enhanced magnetic resonance angiography (CE-MRA), 2D T2 black blood, and 2D cine SSFP.
    Potthast S; Mitsumori L; Stanescu LA; Richardson ML; Branch K; Dubinsky TJ; Maki JH
    J Magn Reson Imaging; 2010 Jan; 31(1):177-84. PubMed ID: 20027585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-spatial-resolution MR angiography of renal arteries with integrated parallel acquisitions: comparison with digital subtraction angiography and US.
    Schoenberg SO; Rieger J; Weber CH; Michaely HJ; Waggershauser T; Ittrich C; Dietrich O; Reiser MF
    Radiology; 2005 May; 235(2):687-98. PubMed ID: 15770035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peripheral arterial occlusive disease: evaluation of a high spatial and temporal resolution 3-T MR protocol with a low total dose of gadolinium versus conventional angiography.
    Attenberger UI; Haneder S; Morelli JN; Diehl SJ; Schoenberg SO; Michaely HJ
    Radiology; 2010 Dec; 257(3):879-87. PubMed ID: 20959539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Post-processing central k-space subtraction for high-resolution arterial peripheral MR angiography.
    Gedat E; Mohajer M; Kirsch R; Frericks B
    Magn Reson Imaging; 2011 Jul; 29(6):835-43. PubMed ID: 21546189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in the assessment of the abdominal aorta and its major branches at 3 Tesla.
    Kramer U; Fenchel M; Laub G; Seeger A; Klumpp B; Bretschneider C; Finn JP; Claussen CD; Miller S
    Acad Radiol; 2010 May; 17(5):564-76. PubMed ID: 20171907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraindividual quantitative and qualitative comparison of gadopentetate dimeglumine and gadobutrol in time-resolved contrast-enhanced 4-dimensional magnetic resonance angiography in minipigs.
    Hadizadeh DR; Jost G; Pietsch H; Weibrecht M; Perkuhn M; Boschewitz JM; Keil VC; Träber F; Kukuk GM; Schild HH; Willinek WA
    Invest Radiol; 2014 Jul; 49(7):457-64. PubMed ID: 24598442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative analysis of ECG-gated high-resolution contrast-enhanced MR angiography of the thoracic aorta.
    Groves EM; Bireley W; Dill K; Carroll TJ; Carr JC
    AJR Am J Roentgenol; 2007 Feb; 188(2):522-8. PubMed ID: 17242264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contrast-enhanced MR angiography of the chest and abdomen with use of controlled apnea in children.
    Saleh RS; Patel S; Lee MH; Boechat MI; Ratib O; Saraiva CR; Finn JP
    Radiology; 2007 Jun; 243(3):837-46. PubMed ID: 17517937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.